Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Fate Therapeutics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $203.5K in total
- Insiders trading
- 2
- Net value
- −$203.5K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Fate Therapeutics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tahl Cindy | See Remarks | 589,355 | Aug 5, 2026 | 5 |
| Valamehr Bahram | President and CEO | 591,815 | Aug 5, 2026 | 4 |
| Redmile Group, LLC | Director, 10% Owner | 12,884,277Indirect | Jun 15, 2026 | 2 |
| Green Jeremy | Director, 10% Owner | 12,884,277Indirect | Jun 15, 2026 | 2 |
| Rastetter William H | Director | 36,331 | Jun 15, 2026 | 2 |
| Epstein Robert S | Director | 36,331 | Jun 15, 2026 | 2 |
| Abernethy Matt | Director | – | Jun 15, 2026 | 1 |
| Agarwal Shefali | Director | 10,490 | Jun 15, 2026 | 1 |
| Lee Michael Stewart | Director | 11,331 | Jun 15, 2026 | 1 |
| Hamill Laura | Director | – | Jun 15, 2026 | 1 |
| Jooss Karin | Director | 9,848 | Jun 15, 2026 | 1 |
| Xu Yuan | Director | 8,669 | Jun 15, 2026 | 1 |
| RedCo II Master Fund, L.P. | Director, 10% Owner | 12,884,277Indirect | Apr 23, 2026 | 1 |
| Adawi Kamal | Chief Financial Officer | 100,000 | Jan 16, 2026 | 2 |
| Mendlein John | Director | 311,231 | May 30, 2025 | 0 |
| Mozaffarian Neelufar | Director | – | May 30, 2025 | 0 |
| Bressi Jerome Charles | See Remarks | 335,203 | Jan 16, 2025 | 0 |
| Coughlin Timothy | Director | 9,892 | Jun 11, 2024 | 0 |
| Dulac Edward J III | Chief Financial Officer | 101,479 | Mar 5, 2024 | 0 |
| Wolchko J Scott | President and CEO | 371,248 | Feb 2, 2024 | 0 |
| Powl Brian T. | Chief Commercial Officer | 41,146 | Jul 6, 2023 | 0 |
| Hershberg Robert | Director | 10,659 | Jun 7, 2023 | 0 |
| Chu Yu-Waye | Chief Medical Officer | 140,676 | Apr 19, 2023 | 0 |
| Plavsic Mark | Chief Technical Officer | 123,705 | Jan 11, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 (view filing) | Jun 14 | 1 day | Xu YuanDirector | SSale | −3.46K | $5.58 | −$19.3K | −25.8%9.93K after | 10b5-1 |
| Jul 6, 2023 (view filing) | Jul 5 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −5.18K | $4.83 | −$25.0K | −4.0%124.3K after | 10b5-1 |
| Jul 6, 2023 (view filing) | Jul 5 | 1 day | Powl Brian T.Chief Commercial Officer | SSale | −3.85K | $4.87 | −$18.8K | −8.6%41.1K after | |
| Aug 7, 2023 (view filing) | Aug 4 | 3 days | Xu YuanDirector | SSale | −632 | $3.71 | −$2.34K | −6.4%9.30K after | 10b5-1 |
| Aug 21, 2023 (view filing) | Aug 18 | 3 days | Dulac Edward J IIIChief Financial Officer | SSale | −4.72K | $2.80 | −$13.2K | −3.8%119.6K after | |
| Nov 13, 2023 (view filing) | Nov 9 | 4 days | Tahl CindyGeneral Counsel and Secretary | SSale | −24.4K | $2.40 | −$58.5K | −13.7%153.2K after | 10b5-1 |
| Dec 19, 2023 (view filing) | Dec 18 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −1.58K | $3.50 | −$5.55K | −1.3%118.0K after | 10b5-1 |
| Dec 28, 2023 (view filing)9:30 PM ET | Dec 26 | 2 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | PPurchase | +44.6K | $3.72 | +$166.0K | +0.3%13.2M after | |
| Jan 3, 2024 (view filing) | Jan 2 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −5.18K | $3.66 | −$19.0K | −4.4%112.8K after | 10b5-1 |
| Jan 10, 2024 (view filing) | Jan 9 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −7.03K | $4.37 | −$30.7K | −6.2%105.8K after | |
| Jan 10, 2024 (view filing) | Jan 9 | 1 day | Wolchko J ScottPresident and CEO | SSale | −14.4K | $4.37 | −$62.9K | −3.7%371.2K after | |
| Jan 10, 2024 (view filing) | Jan 9 | 1 day | Valamehr BahramChief R&D Officer | SSale | −11.3K | $4.38 | −$49.4K | −6.7%158.1K after | |
| Jan 10, 2024 (view filing) | Jan 9 | 1 day | Tahl CindyGeneral Counsel and Secretary | SSale | −10.9K | $4.37 | −$47.5K | −7.1%142.4K after | |
| Jan 30, 2024 (view filing) | Jan 29 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −1.85K | $5.00 | −$9.24K | −1.7%103.9K after | 10b5-1 |
| Mar 5, 2024 (view filing) | Mar 4 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −2.45K | $7.77 | −$19.0K | −2.4%101.5K after | 10b5-1 |
| Aug 7, 2024 (view filing) | Aug 6 | 1 day | Xu YuanDirector | SSale | −633 | $4.23 | −$2.68K | −6.8%8.67K after | 10b5-1 |
| Dec 26, 2024 (view filing)9:00 PM ET | Dec 20 | 6 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | SSale | −341.6K | $1.68 | −$573.9K | −2.7%12.5M after | |
| Dec 26, 2024 (view filing)9:00 PM ET | Dec 20 | 6 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | PPurchase | +398.0K | $1.68 | +$668.6K | +3.2%12.9M after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Valamehr BahramPresident and CEO | SSale | −8.71K | $1.54 | −$13.4K | −2.4%349.4K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Tahl CindySee Remarks | SSale | −5.65K | $1.55 | −$8.76K | −1.7%336.7K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Bressi Jerome CharlesSee Remarks | SSale | −5.98K | $1.55 | −$9.27K | −2.2%270.2K after | |
| Aug 5, 2025 (view filing) | Aug 4 | 1 day | Valamehr BahramPresident and CEO | SSale | −14.5K | $1.06 | −$15.3K | −4.1%334.9K after | |
| Aug 5, 2025 (view filing) | Aug 4 | 1 day | Tahl CindySee Remarks | SSale | −9.04K | $1.06 | −$9.58K | −2.2%397.7K after | |
| Jan 12, 2026 (view filing) | Jan 9 | 3 days | Valamehr BahramPresident and CEO | SSale | −5.19K | $1.07 | −$5.55K | −1.5%329.7K after | |
| Jan 12, 2026 (view filing) | Jan 9 | 3 days | Tahl CindySee Remarks | SSale | −10.6K | $1.06 | −$11.2K | −2.7%387.1K after | |
| May 21, 2026 (view filing) | May 20 | 1 day | Valamehr BahramPresident and CEO | SSale | −28.9K | $1.88 | −$54.4K | −4.4%635.8K after | |
| May 21, 2026 (view filing) | May 20 | 1 day | Tahl CindySee Remarks | SSale | −25.6K | $1.88 | −$48.1K | −3.9%628.2K after | |
| Aug 5, 2026 (view filing)4:01 PM ET | Aug 4 | 1 day | Valamehr BahramPresident and CEO | SSale | −43.9K | $2.46 | −$108.1K | −6.9%591.8K after | |
| Aug 5, 2026 (view filing)4:03 PM ET | Aug 4 | 1 day | Tahl CindySee Remarks | SSale | −38.8K | $2.46 | −$95.4K | −6.2%589.4K after |